# Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

> **NCT00108771** · PHASE2 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 202 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ZR-02-01 Fentanyl Transdermal Matrix Patch
- **DRUG:** Placebo Patch

## Key facts

- **NCT ID:** NCT00108771
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108771, "Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00108771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*